Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $152.7700 (-5.79%) ($151.5100 - $162.9500) on Tue. Dec. 4, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.14% (three month average) | RSI | 56 | Latest Price | $152.7700(-5.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND advances 3.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.57% in a week (0% probabilities). TLT(-16%) VXX(-15%) VIXM(-11%) UUP(-9%) DIA(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.57% (StdDev 3.14%) | Hourly BBV | 0 () | Intraday Trend | -6.1% | | | |
|
Resistance Level | $156 | 5 Day Moving Average | $160(-4.52%) | 10 Day Moving Average | $156.33(-2.28%) | 20 Day Moving Average | $156(-2.07%) | To recent high | -44.3% | To recent low | 3.4% | Market Cap | $2.455b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |